Surveillance to estimate the burden of rotavirus gastroenteritis in children aged less than 3 years attending day care centers in Paris, France

Human Vaccines

Volumn 6, Issue 5, 2010, Pages 399-406

  Grimprel, Emmanuel ^a   Garbarg Chenon, Antoine ^a   Pirçon, Jean Yves ^b   Curran, Desmond ^c   Soriano Gabarró, Montse ^b   Meyer, Nadia ^b  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c Omega Research   (Ireland)

Author keywords

Day care centers; Disease burden; Rotavirus gastroenteritis; Vaccination

Indexed keywords

ROTAVIRUS VACCINE;

ACUTE GASTROENTERITIS; ARTICLE; CHILD; CHILD CARE; CLINICAL FEATURE; DISEASE SEVERITY; FECES ANALYSIS; FEMALE; FRANCE; HEALTH CARE COST; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PARENTAL BEHAVIOR; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; ROTAVIRUS INFECTION;

EID: 77953705804     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.6.5.11021     Document Type: Article

References (72)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565-72.
2. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12:304-30.
3. Forster J, Guarino A, Parez N, Moraga F, Román E, Mory O, et al. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children aged <5 years. Pediatrics 2009; 123:393-400.
4. Pickering LK, Bartlett AV, Woodward WE. Acute infectious diarrhea among children in day care: epidemiology and control. Rev Infect Dis 1986; 8:539-47.
5. Bartlett AV, 3rd, Reves RR, Pickering LK. Rotavirus in infant-toddler day care centers: epidemiology relevant to disease control strategies. J Pediatr 1988; 113:435-41.
6. Reves RR, Morrow AL, Bartlett AV, 3rd, Caruso CJ, Plumb RL, Lu BT, Pickering LK. Child day care increases the risk of clinic visits for acute diarrhea and diarrhea due to rotavirus. Am J Epidemiol 1993; 137:97-107.
7. Ferson MJ, Stringfellow S, McPhie K, McIver CJ, Simos A. Longitudinal study of rotavirus infection in child-care centres. J Paediatr Child Health 1997; 33:157-60. (Pubitemid 27223804)
8. Louhiala PJ, Jaakkola N, Ruotsalainen R, Jaakkola JJ. Day-care centers and diarrhea: a public health perspective. J Pediatr 1997; 131:476-9. (Pubitemid 27495218)
9. Ford-Jones EL, Wang E, Petric M, Corey P, Moineddin R, Fearon M. Rotavirus-associated diarrhea in outpatient settings and child care centers. Arch Pediatr Adolesc Med 2000; 154:586-93. (Pubitemid 30387379)
10. Lu N, Samuels ME, Shi L, Baker SL, Glover SH, Sanders JM. Child day care risks of common infectious diseases revisited. Child Care Health Dev 2004; 30:361-8. (Pubitemid 38960812)
11. Rosenfeldt V, Vesikari T, Pang XL, Zeng SQ, Tvede M, Paerregaard A. Viral etiology and incidence of acute gastroenteritis in young children attending day-care centers. Pediatr Infect Dis J 2005; 24:962-5. (Pubitemid 41689597)
12. Zutavern A, Rzehak P, Brockow I, Schaaf B, Bollrath C, von Berg A, et al. Day care in relation to respiratorytract and gastrointestinal infections in a German birth cohort study. Acta Paediatr 2007; 96:1494-9.
13. Lyman WH, Walsh JF, Kotch JB, Weber DJ, Gunn E, Vinjé J. Prospective study of etiologic agents of acute gastroenteritis outbreaks in child care centers. J Pediatr 2009; 154:253-7.
14. World Health Organization. Rotavirus vaccines. WHO position paper. Wkly Epidemiol Rec 2007; 82:285-96.
15. Meeting of the immunization Strategic Advisory Group of Experts, April 2009 - conclusions and recommendations. Wkly Epidemiol Rec 2009; 84:220-36.
16. Floret D, Lina B, Pinchinat S, Billaud G, Aït-Belghiti F, Largeron N, et al. Epidemiology and burden of rotavirus diarrhea in day care centers in Lyon, France. Eur J Pediatr 2006; 165:905-6.
17. Fau C, Billaud G, Pinchinat S, Lina B, Kaplon J, Pothier P, et al. Epidemiology and burden of rotavirus diarrhea in day care centers in Lyon, France. Arch Pediatr 2008; 15:1183-92. (Pubitemid 44627778)
18. Buttery JP, Mayon-White RT, Davison K, Ramsay M, Sweetman WA, Diggle L, et al. Clinical and cost impact of rotavirus diarrhea in Oxfordshire nurseries and primary care patients. Arch Dis Childhood 2001; 84:61.
19. Gray J, Vesikari T, Van Damme P, Giaquinto C, Mrukowicz J, Guarino A, et al. Rotavirus. J Ped Gastroenterol Nutr 2008; 46:24-31.
20. Hjelt K, Nielson OH, Paerregaard A, Grauballe PC, Krasilnikoff PA. Acute gastroenteritis in children attending day-care centres with special reference to rotavirus infections II. Clinical manifestations. Acta Paediatr Scand 1987; 76:763-8. (Pubitemid 17154944)
21. Soriano-Gabarró M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006; 25:7-11. (Pubitemid 43884460)
22. Van Damme P, Giaquinto C, Huet F, Gothefors L, Maxwell M, Van der Wielen M; REVEAL Study Group. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: The REVEAL Study. J Infect Dis 2007; 195:4-16.
23. Koopmans M, Brown D. Seasonality and diversity of Group A rotaviruses in Europe. Acta Paediatr Suppl 1999; 88:14-9. (Pubitemid 29095611)
24. Albano F, Bruzzese E, Bella A, Cascio A, Titone L, Arista S, et al. Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study. Eur J Pediatr 2007; 166:241-7. (Pubitemid 46352517)
25. Colomba C, Saporito L, Giammanco GM, De Grazia S, Ramirez S, Arista S, Titone L. Norovirus and gastroenteritis in hospitalized children, Italy. Emerg Infect Dis 2007; 13:1389-91.
26. Giaquinto C, Van Damme P, Huet F, Gothefors L, Maxwell M, Todd P, da Dalt L; REVEAL Study Group. Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis 2007; 195:26-35.
27. Junquera CG, de Baranda CS, Mialdea OG, Serrano EB, Sánchez- Fauquier A. Prevalence and clinical characteristics of norovirus gastroenteritis among hospitalized children in Spain. Pediatr Infect Dis J 2009; 28:604-7.
28. de Rougemont A, Kaplon J, Lebon P, Huet F, Denis F, Alain S, et al. Unexpected substitution of dominant rotavirus G genotypes in French hospitalized children over five consecutive seasons. Eur J Clin Microbiol Infect Dis 2009; 28:403-7.
29. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005; 15:29-56. (Pubitemid 40070041)
30. Desselberger U, Wolleswinkel-van den Bosch J, Mrukowicz J, Rodrigo C, Giaquinto C, Vesikari T. Rotavirus types in Europe and their significance for vaccination. Pediatr Infect Dis J 2006; 25:30-41.
31. de Castro L, Rodrigues Ddos P, Flauzino R, Moura M, Leite JP. An outbreak of diarrhoea associated with rotavirus serotype 1 in a day care nursery in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 1994; 89:5-9.
32. Taylor MB, Marx FE, Grabow WO. Rotavirus, astrovirus and adenovirus associated with an outbreak of gastroenteritis in a South African child care centre. Epidemiol Infect 1997; 119:227-30.
33. Widdowson MA, van Doornum GJ, van der Poel WH, de Boer AS, van de Heide R, Mahdi U, et al. An outbreak of diarrhea in a neonatal medium care unit caused by a novel strain of rotavirus: investigation using both epidemiologic and microbiological methods. Infect Control Hosp Epidemiol 2002; 23:665-70. (Pubitemid 35315989)
34. Ramani S, Sowmyanarayanan TV, Gladstone BP, Bhowmick K, Asirvatham JR, Jana AK, et al. Rotavirus infection in the neonatal nurseries of a tertiary care hospital in India. Pediatr Infect Dis J 2008; 27:719-23.
35. Rogers M, Weinstock DM, Eagan J, Kiehn T, Armstrong D, Sepkowitz KA. Rotavirus outbreak on a pediatric oncology floor: possible association with toys. Am J Infect Control 2000; 28:378-80.
36. Barrón-Romero BL, Barreda-González J, Doval-Ugalde R, Zermeño-Eguia LJ, Huerta-Peña M. Asymptomatic rotavirus infections in day care centers. J Clin Microbiol 1985; 22:116-8.
37. Pickering LK, Bartlett AV, 3rd, Reves RR, Morrow A. Asymptomatic excretion of rotavirus before and after rotavirus diarrhea in children in day care centers. J Pediatr 1988; 112:361-5.
38. Keswick BH, Pickering LK, DuPont HL, Woodward WE. Survival and detection of rotaviruses on environmental surfaces in day care centers. Appl Environ Microbiol 1983; 46:813-6.
39. Wilde J, Van R, Pickering L, Eiden J, Yolken R. Detection of rotaviruses in the day care environment by reverse transcriptase polymerase chain reaction. J Infect Dis 1992; 166:507-11.
40. Butz AM, Fosarelli P, Dick J, Cusack T, Yolken R. Prevalence of rotavirus on high-risk fomites in day-care facilities. Pediatrics 1993; 92:202-5.
41. Dennehy PH. Transmission of rotavirus and other enteric pathogens in the home. Pediatr Infect Dis J 2000; 19:103-5.
42. Heymann DL. Control of Communicable Diseases Manual. 18th edition. Washington DC, USA: American Public Health Association 2004.
43. Kapikian AZ, Wyatt RG, Levine MM, Yolken RH, Van Kirk DH, Dolin R, et al. Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J Infect Dis 1983; 147:95-106.
44. Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR, Schiff GM. Human rotavirus studies in volunteers: Determination of infectious dose and serological response to infection. J Infect Dis 1986; 154:871-80.
45. Mrukowicz J, Szajewska H, Vesikari T. Options for the prevention of rotavirus disease other than vaccination. J Pediatr Gastroenterol Nutr 2008; 46:32-7.
46. Ansari SA, Springthorpe VS, Sattar SA. Survival and vehicular spread of human rotaviruses: possible relation to seasonality of outbreaks. Rev Infect Dis 1991; 13:448-61.
47. Gerba CP, Kennedy D. Enteric virus survival during household laundering and impact of disinfection with sodium hypochlorite. Appl Environ Microbiol 2007; 73:4425-8. (Pubitemid 47122584)
48. Richardson S, Grimwood K, Gorrell R, Palombo E, Barnes G, Bishop R. Extended excretion of rotavirus after severe diarrhoea in young children. Lancet 1998; 351:1844-8. (Pubitemid 28279708)
49. von Bonsdorff CH, Hovi T, Mákelá P, Hovi T, Tevalvoto-Aarnio M. Rotavirus associated with acute gastroenteritis in adults. Lancet 1976; 2:423.
50. Wenman WM, Hinde D, Feltham S, Gurwith M. Rotavirus infection in adults. Results of a prospective family study. N Engl J Med 1979; 301:303-6. (Pubitemid 9244493)
51. Barnes GL, Callaghan SL, Kirkwood CD, Bogdanovic-Sakran N, Johnston LJ, Bishop RF. Excretion of serotype G1 rotavirus strains by asymptomatic staff: a possible source of nosocomial infection. J Pediatr 2003; 142:722-5. (Pubitemid 36737179)
52. Banerjee I, Gladstone BP, Iturriza-Gomara M, Gray JJ, Brown DW, Kang G. Evidence of intrafamilial transmission of rotavirus in a birth cohort in South India. J Med Virol 2008; 80:1858-63.
53. Standaert B, Parez N, Tehard B, Colin X, Detournay B. Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France. Appl Health Econ Health Policy 2008; 6:199-216.
54. Vesikari T, Van Damme P, Giaquinto C, Gray J, Mrukowicz J, Dagan R, et al. European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology and Nutrition evidence-based recommendations for rotavirus vaccination in Europe. J Pediatr Gastroenterol Nutr 2008; 46:38-48.
55. Grimwood K, Lambert SB. Rotavirus vaccines: opportunities and challenges. Hum Vaccin 2009; 5:57-69.
56. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22. (Pubitemid 43048947)
57. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33. (Pubitemid 43048948)
58. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-63.
59. Linhares AC, Velázquez FR, Pérez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371:1181-9.
60. Phua KB, Lim FS, Lau YL, Nelson EAS, Huang LM, Quak SH, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine 2009; 27:5936-41.
61. th Annual Meeting of the European Society for Paediatric Infectious Diseases: Brussels, Belgium 2009.
62. Vesikari T, Itzler R, Karvonen A, Korhonen T, Van Damme P, Behre U, et al. RotaTeq((R)), a pentavalent rotavirus vaccine: Efficacy and safety among infants in Europe. Vaccine 2009; 28:345-51.
63. Centers for Disease Control and Prevention (CDC). Reduction in rotavirus after vaccine introduction - United States, 2000-2009. MMWR Morb Mortal Wkly Rep 2009; 58:1146-9.
64. Chang HG, Smith PF, Tserenpuntsag B, Markey K, Parashar U, Morse DL. Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine. Vaccine 2009; Epub ahead of print.
65. Clark HF, Lawley D, Mallette LA, DiNubile MJ, Hodinka RL. Decline in cases of rotavirus gastroenteritis presenting to The Children's Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine. Clin Vaccine Immunol 2009; 16:382-6.
66. Gurgel RI, Bohland AN, Vieira SA, Oliveira DO, Fontes PA, Barros VI, et al. Incidence of rotavirus and all-cause diarrhea in Northeast Brazil following the introduction of a national vaccination program. Gastroenterology 2009; Epub ahead of print.
67. Iturriza-Gómara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol 2004; 31:259-65. (Pubitemid 39371057)
68. Kühne Simmonds M, Armah G, Asmah R, Banerjee I, Damanka S, Esona M, et al. New oligonucleotide primers for P typing of rotavirus strains: Strategies for typing previously untypable strains. J Clin Virol 2008; 42:368-73.
69. Iturriza-Gómara M, Wong C, Blome S, Desselberger U, Gray J. Molecular characterization of VP6 genes of human rotavirus isolates: correlation of genogroups with subgroups and evidence of independent segregation. J Virol 2002; 76:6596-601. (Pubitemid 34633525)
70. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990; 22:259-67.
71. VIDAL. Available at: http://www.vidal.fr/. Accessed 2009.
72. Standaert B, Harline O, Desselburger U. The financial burden of rotavirus disease in four countries of the European Union. Pediatr Infect Dis J 2008; 27:20-7.